NCT05034380

Brief Summary

The purpose of this study is to determine the ability of acute exercise to regulate fat metabolism in muscle of overweight and obese people compared to lean people.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 6, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2016

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

September 16, 2020

Completed
12 months until next milestone

First Posted

Study publicly available on registry

September 5, 2021

Completed
Last Updated

September 5, 2021

Status Verified

August 1, 2021

Enrollment Period

1.1 years

First QC Date

September 16, 2020

Last Update Submit

August 28, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change from baseline in skeletal muscle acylcarnitines

    Metabolomics of skeletal muscle acylcarnitines is used as a measure of mitochondrial function by assessing long, medium and short chain acylcarnitine levels.

    Baseline and immediately after acute cycling exercise

  • Change from baseline in skeletal transcriptome

    RNA-seq is a method used to quantify changes in all known messenger RNA levels in the genome, giving an assessment of whole genome gene transcription changes.

    Baseline and immediately after acute cycling exercise

  • Change from baseline in skeletal muscle whole genome nucleosome maps

    MNase-seq is a method used to determine the occupancy/location of nucleosomes throughout the entire genome, supporting evidence of alterations in epigenetic modifications occurring at specific genomic loci that affect nucleosome occupancy/location and possibly gene transcription or silencing.

    Baseline and immediately after acute cycling exercise

Secondary Outcomes (5)

  • Glucose

    Baseline and immediately after acute cycling exercise

  • Insulin

    Baseline and immediately after acute cycling exercise

  • Triglycerides

    Baseline and immediately after acute cycling exercise

  • Free fatty acids

    Baseline and immediately after acute cycling exercise

  • Cholesterol

    Baseline and immediately after acute cycling exercise

Study Arms (2)

Lean

ACTIVE COMPARATOR

males aged 18-30 years with BMI \< 25

Behavioral: Acute exercise

Overweight/Obese

EXPERIMENTAL

males aged 18-30 years with BMI \>= 25

Behavioral: Acute exercise

Interventions

Acute exerciseBEHAVIORAL

All participants consumed a standardized, high carbohydrate meal (7 kcal/kg; 60% carbohydrate, 25% fat, 15% protein) and completed an exercise testing trial, expending a total of 650 kcal upon completion 4h later.

LeanOverweight/Obese

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy males that completed a physical examination with a State Licensed M.D. or D.O. within the past 2 years and completed a physical activity readiness questionnaire (PARQ), the International Physical Activity Questionnaires (IPAQ) and and a medical history questionnaire prior to the study

You may not qualify if:

  • any participants that had not had a physical examination by a State Licensed M.D. or D.O. within the past 2 years
  • persons not considered "healthy" (with any previous medical diagnoses) or not medically cleared by a M.D. or D.O. to perform physical activity/exercise
  • persons who are regularly physically active

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Purdue University

West Lafayette, Indiana, 47907, United States

Location

MeSH Terms

Conditions

ObesityDiabetes Mellitus, Type 2Cardiovascular Diseases

Interventions

Exercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Tara Henagan, PhD

    Purdue University, Louisiana State University Medical School at Shreveport

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Investigators conducting molecular analysis were blinded to study samples/groups.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: All participants underwent the same exact study protocol on random days throughout the study period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 16, 2020

First Posted

September 5, 2021

Study Start

September 14, 2014

Primary Completion

October 6, 2015

Study Completion

March 14, 2016

Last Updated

September 5, 2021

Record last verified: 2021-08

Locations